Literature DB >> 20876940

TP53 and MTOR crosstalk to regulate cellular senescence.

Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer.   

Abstract

The full spectrum of activities of the tumor suppressor p53 (TP53) has not been completely elucidated yet. Recently, it was demonstrated that TP53 communicates with the metabolic regulator mechanistic target of rapamycin (MTOR) to determine whether stressed cells undergo cell death, reversible quiescence or irreversible senescence, thereby adding yet another level of complexity to the signaling network that emanate from TP53.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876940      PMCID: PMC2984599          DOI: 10.18632/aging.100202

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  12 in total

1.  Can autophagy promote longevity?

Authors:  Frank Madeo; Nektarios Tavernarakis; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

2.  A new role for cytoplasmic p53: binding and destroying double-stranded RNA.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Guido Kroemer
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

3.  Paradoxical suppression of cellular senescence by p53.

Authors:  Zoya N Demidenko; Lioubov G Korotchkina; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

4.  Stimulation of autophagy by the p53 target gene Sestrin2.

Authors:  Maria Chiara Maiuri; Shoaib Ahmad Malik; Eugenia Morselli; Oliver Kepp; Alfredo Criollo; Pierre-Luc Mouchel; Rosa Carnuccio; Guido Kroemer
Journal:  Cell Cycle       Date:  2009-05-20       Impact factor: 4.534

5.  Mechanisms of p53-mediated mitochondrial membrane permeabilization.

Authors:  Eugenia Morselli; Lorenzo Galluzzi; Guido Kroemer
Journal:  Cell Res       Date:  2008-07       Impact factor: 25.617

6.  A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

Authors:  B D Chang; E V Broude; M Dokmanovic; H Zhu; A Ruth; Y Xuan; E S Kandel; E Lausch; K Christov; I B Roninson
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

Review 7.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 8.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

Review 9.  Autophagy regulation by p53.

Authors:  Maria Chiara Maiuri; Lorenzo Galluzzi; Eugenia Morselli; Oliver Kepp; Shoaib Ahmad Malik; Guido Kroemer
Journal:  Curr Opin Cell Biol       Date:  2010-01-13       Impact factor: 8.382

10.  p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.

Authors:  Andrei V Budanov; Michael Karin
Journal:  Cell       Date:  2008-08-08       Impact factor: 41.582

View more
  56 in total

1.  Rapamycin induces pluripotent genes associated with avoidance of replicative senescence.

Authors:  Tatiana V Pospelova; Tatiana V Bykova; Svetlana G Zubova; Natalia V Katolikova; Natalia M Yartzeva; Valery A Pospelov
Journal:  Cell Cycle       Date:  2013-12-02       Impact factor: 4.534

Review 2.  Radiation-Induced Bystander Response: Mechanism and Clinical Implications.

Authors:  Keiji Suzuki; Shunichi Yamashita
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-01-01       Impact factor: 4.730

3.  Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells.

Authors:  Fengchun Ye; Ali Abdul Lattif; Jianping Xie; Aaron Weinberg; Shoujiang Gao
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

4.  TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death.

Authors:  M Seillier; S Peuget; O Gayet; C Gauthier; P N'Guessan; M Monte; A Carrier; J L Iovanna; N J Dusetti
Journal:  Cell Death Differ       Date:  2012-03-16       Impact factor: 15.828

Review 5.  Rapalogs in cancer prevention: anti-aging or anticancer?

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2012-11-14       Impact factor: 4.742

Review 6.  Controversial aspects of oncogene-induced senescence.

Authors:  Anna Bianchi-Smiraglia; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

7.  FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.

Authors:  Bulbul Pandit; Andrei L Gartel
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

8.  cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response.

Authors:  Harsha S Madapura; Daniel Salamon; Klas G Wiman; Sonia Lain; Eva Klein; Noémi Nagy
Journal:  Cell Cycle       Date:  2016-05-02       Impact factor: 4.534

9.  Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins.

Authors:  Federico Pietrocola; Guillermo Mariño; Delphine Lissa; Erika Vacchelli; Shoaib Ahmad Malik; Mireia Niso-Santano; Naoufal Zamzami; Lorenzo Galluzzi; Maria Chiara Maiuri; Guido Kroemer
Journal:  Cell Cycle       Date:  2012-10-15       Impact factor: 4.534

10.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.